1 Result(s)

Article

Phase I and pharmacokinetic study of the combination of topotecan and ifosfamide administered intravenously every 3 weeks

To determine the maximum-tolerated dose (MTD), dose-limiting toxicities, and pharmacokinetics of topotecan administered as a 30-min intravenous (i.v.) infusion over 5 days in combination with a 1-h i.v. infusi...

T Kerbusch, G Groenewegen, R A A Mathôt, V M M Herben… in British Journal of Cancer (2004)